PDL BIOPHARMA INC's ticker is and the CUSIP is 69329YAF1. A total of 27 filers reported holding PDL BIOPHARMA INC in Q4 2015. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $22,000 | 0.0% | 22,000 | 0.0% | 0.00% | – |
| Q2 2017 | $22,000 | 0.0% | 22,000 | 0.0% | 0.00% | – |
| Q1 2017 | $22,000 | +4.8% | 22,000 | 0.0% | 0.00% | – |
| Q4 2016 | $21,000 | 0.0% | 22,000 | 0.0% | 0.00% | – |
| Q3 2016 | $21,000 | 0.0% | 22,000 | 0.0% | 0.00% | – |
| Q2 2016 | $21,000 | +5.0% | 22,000 | 0.0% | 0.00% | – |
| Q1 2016 | $20,000 | +11.1% | 22,000 | 0.0% | 0.00% | – |
| Q4 2015 | $18,000 | – | 22,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Radcliffe Capital Management, L.P. | 19,703,000 | $19,738,000 | 2.83% |
| ASCEND CAPITAL, LLC | 43,840,000 | $43,727,000 | 1.65% |
| ZAZOVE ASSOCIATES LLC | 2,080,000 | $2,085,000 | 0.11% |
| Verition Fund Management LLC | 1,000,000 | $1,004,000 | 0.08% |
| OAKTREE CAPITAL MANAGEMENT LP | 4,940,000 | $4,940,000 | 0.07% |
| COMMONWEALTH OF PENNSYLVANIA PUBLIC SCHOOL EMPLS RETRMT SYS | 3,420,000 | $3,424,000 | 0.05% |
| UBS ASSET MANAGEMENT AMERICAS LLC | 37,800,000 | $37,702,476,000 | 0.03% |
| Sterneck Capital Management, LLC | 18,000 | $18,000 | 0.01% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 235,000 | $212,000 | 0.00% |
| INVESTMENT CENTERS OF AMERICA INC | 50,000 | $50,000 | 0.00% |